Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
VIROPHARMA (NQ: VPHM)
+0.00 (0.00%)
at
9.740
911,666 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 9.490
Bid (Size) 9.730 (14800)
Ask (Size) 9.740 (600)
Prev. Close 9.740
Today's Range 9.320 - 9.800
52wk Range 3.790 - 10.74
Shares Outstanding 77,442,716
Morningstar Profile
View Full Profile
VIROPHARMA
A biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 754.29M
Related Companies SVNT PDLI ALTH NEOG
Featured News
Read More
ViroPharma Provides 2010 Cinryze(TM) (C1 Esterase Inhibitor [Human]) Outlook
Jan 11, 2010
- Company Also Provides Update to U.S. Hereditary Angioedema (HAE) Peak Year Sales Estimates - Read More
from PRNewsWire News Releases
ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])
Jan 11, 2010
- Agreement with Sanquin Provides Additional Opportunities for Growth through Expansion of Territories and New Indications - Read More
from PRNewsWire News Releases
Featured News
Read More
ViroPharma to Participate in the 28th Annual J.P. Morgan Healthcare Conference
Jan 06, 2010
from PRNewsWire News Releases
ViroPharma to Present at Three November Healthcare Conferences
Oct 29, 2009
from PRNewsWire News Releases
ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Oct 28, 2009
from PRNewsWire News Releases
ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
Oct 15, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA